← Back to patent-cliff list
利托那韦
Tier C — Watch / tradeRitonavir
艾伯维
Originator
1996
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：HIV-1 protease
Brand：Norvir、迈可欣、爱治威
Indications (approved)：HIV感染
Regional status
US
撤市
EU
批准上市
1996-08-25
China
批准上市
2002-08-29
Japan
批准上市
1998-09-25
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ritonavir?
Approved indications include: HIV感染.
When does the Ritonavir patent expire?
No public expiry year is available for Ritonavir yet; this page updates once verified.
How do I get a quote for Ritonavir intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25